AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06095648 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dose of platelet transfusion
Description: Intervention is using a lower (5ml/kg) compared to usual (15ml/kg) dose of platelets for transfusion in non-bleeding babies born at or before 32 weeks in NICU
Study NCT05629325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buspirone Hydrochloride 10 MG
Description: 4 weeks of treatment with buspirone
Study NCT05629325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 4 weeks of treatment with placebo
Study NCT06213727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lowe-dose ZKY001 eye drops
Description: eye drops
Study NCT06213727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medium-dose ZKY001 eye drops
Description: eye drops
Study NCT06213727 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ZKY001 simulated eye drops
Description: eye drops
Study NCT05403983 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga movement intervention
Description: Mixture of yoga, tai chi, pilates. Will be delivered in person (experimental) and online (active comparator)
Study NCT05403983 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Yoga movement intervention
Description: Mixture of yoga, tai chi, pilates. Will be delivered in person (experimental) and online (active comparator)
Study NCT05403983 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education booklet
Description: Recently published postpartum physical activity guidebook through the Sport Information Resource Center of Canada
Study NCT05624008 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bioceramic glass ionomer restoration
Description: bioactive glass ionomer with unique biocompatibility and biological regenerative properties
Study NCT05624008 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resin modified glass ionomer restoration
Description: A hybrid of glass ionomer and composite resin with acid-base and polymerizable components
Study NCT05722379 — intervention group
Intervention type: PROCEDURE
Intervention: left bundle branch pacing (LBBP)
Description: After recording the His potential, the 3830-69 lead (Medtronic Inc., Minneapolis, MN USA) was sent 1-2 cm forward and downward to find the insertion point of the right side of intra-ventricular septum combined with the pre-rotation impedance and ECG changes. Ultimately, the tip was perpendicularly straightforward posited against the septum to the left septal side .
Study NCT05722379 — intervention group
Intervention type: PROCEDURE
Intervention: Right ventricular pacing (RVP)
Description: Right ventricular pacing (RVP) is the standard treatment for patients with continuous ventricular pacing needs.
Study NCT05070884 — intervention group
Intervention type: OTHER
Intervention: The development of new clinical AI solutions to predict treatment response to neoadjuvant chemotherapy (NAC) in breast cancer
Description: Evaluate response to neoadjuvant treatment in advanced breast cancer
Study NCT06297278 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Exercise
Description: Participants randomized to the active (moderate intensity) exercise condition will complete a 3-minute warm-up at low speed on a treadmill. Speed and incline will be increased in 3-minute increments until moderate-intensity exercise, defined as participants staying within a zone of 60-80% AAMHR with the target being to attain and maintain 70-75% AAMHR while briskly walking and/or jogging depending on current fitness status, is reached for a total of 30 min.
Study NCT05241977 — intervention group
Intervention type: PROCEDURE
Intervention: anterior supra scapular nerve block
Description: nerve block for postoperative pain
Study NCT05219916 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood collection.
Description: One additional 80 mL blood collection will be collected from HIV patients during a scheduled blood collection as part of their regular follow-up.~Samples will be transported within 3-5 hours by a carrier approved for the transportation of infectious biological samples from the Croix Rousse hospital to the P3 laboratory of the Ecole Normale Supérieure, Lyon for analysis.
Study NCT06548711 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous Acupoint Electrical Stimulation (TAES)
Description: Transcutaneous acupoint electrical stimulation (TAES) is a non-invasive treatment method that delivers gentle electrical pulses through the skin to specific acupuncture points on the body. This technique aims to mimic the effects of traditional acupuncture, providing a convenient and painless method of treatment.
Study NCT06548711 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcutaneous Acupoint Electrical Stimulation (TAES)
Description: Transcutaneous acupoint electrical stimulation (TAES) is a non-invasive treatment method that delivers gentle electrical pulses through the skin to specific acupuncture points on the body. This technique aims to mimic the effects of traditional acupuncture, providing a convenient and painless method of treatment.
Study NCT06207266 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: emotion intelligence program
Description: The programme was established using research that described emotional intelligence components and their applicability to patients suffering from substance abuse. it considers as awareness program.
Study NCT05458336 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal lavages with Tonimer Panthexyl®
Description: At the moment of diagnosis, patients were asked to fill out an ad hoc questionnaire to subjectively evaluate symptoms and comorbidities at the moment of diagnosis and of negativization. Subjects performed a daily nasal swab. When the subjects tested negative for the first time, they had to complete the questionnaire once again. Patients were given nasal washes (Tonimer Panthexyl®) to be performed three times a day, and in any case after nasal swab.
Study NCT06228677 — intervention group
Intervention type: PROCEDURE
Intervention: Selective adrenal artery embolization
Description: Percutaneous selective adrenal artery embolization in patients with primary aldosteronism
Study NCT06171841 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: low-intensity resistance training
Description: 4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normoxic conditions performed twice a week for 6 weeks.
Study NCT06171841 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: high-intensity resistance training
Description: 4 sets of 10 repetitions of leg press exercise at 70-80% one-repetition maximum (weeks 1-3: 70%, weeks 4-6: 80%) in normoxic conditions performed twice a week for 6 weeks.
Study NCT06171841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-intensity resistance training combined with blood flow restriction
Description: 4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normoxic conditions with lower-limbs blood flow restriction (80% total occlusion pressure) performed twice a week for 6 weeks.
Study NCT06171841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-intensity resistance training in hypoxia condition
Description: 4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in hypoxia conditions (3500 meters above sea) performed twice a week for 6 weeks.
Study NCT06171841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-intensity resistance training combined with blood flow restriction in hypoxia condition
Description: 4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normobaric hypoxia conditions (3500 meters above sea) with lower-limbs blood flow restriction (80% total occlusion pressure) performed twice a week for 6 weeks.
Study NCT04988100 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: splenic artery ligation
Description: Splenic artery will be ligated just after takeoff from coeliac trunk at the level of body of pancreas
Study NCT04988100 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: No intervention
Description: Splenic artery is not ligated despite the presence of portal hyperperfusion
Study NCT06334094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozanimod
Description: A hard capsule that is taken daily for one year.
Study NCT05790278 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: Completion of a Purpose in Life Survey
Study NCT05680987 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: RFN-Advanced Retrograde Femoral Nailing System
Description: RFN-Advanced Retrograde Femoral Nailing System for patients with a distal femur or femoral shaft fracture requiring surgery
Study NCT04734899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise program
Description: Strengthening with resistance bands for tibialis posterior, tibialis anterior, peroneus longus, finger flexors, hip and knee muscles, sheet gathering exercises, fingertip walking exercises, Stretching exercises for gastrocnemius and soleus muscles, plantar fascia stretching, weight transfer on one leg
Study NCT04734899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise program
Description: Strengthening with resistance bands for tibialis posterior, tibialis anterior, peroneus longus, finger flexors, hip and knee muscles, sheet gathering exercises, fingertip walking exercises, Stretching exercises for gastrocnemius and soleus muscles, plantar fascia stretching, weight transfer on one leg
Study NCT04734899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot core training
Description: Short foot exercises with passive modeling, active assisted modeling, active modeling, functional training
Study NCT06044441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ENABLE-SG model
Description: Patients and caregivers will receive individual structured psycho-educational sessions with a health coach. These sessions will be primarily delivered over the phone. Patient and caregiver dyads will have different health coaches. Patients will have six sessions on the topics of maintaining positivity, self-care, coping with stress, managing symptoms, exploring what matters most, and life review. Caregivers will have four sessions on the topics of maintaining positivity, self-care, coping with stress, and managing symptoms. All sessions will begin with screening for distress using the Distress Thermometer and Problem List culturally adapted from the National Comprehensive Cancer Network. From screening results, the health coach can flexibly change the order of the topics to address specific problems. It will take approximately three months to complete all sessions.
Study NCT06044441 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Wait-list control
Description: * 6-month wait-list control. Participants will receive the ENABLE-SG model six months after baseline (six sessions for patients and four sessions for caregivers) at an approximately weekly interval.~* Interventions: ENABLE-SG model
Study NCT04784442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 180mg of ETC-1002(bempedoic acid)
Description: 180mg, tablet, once daily, for 12 weeks
Study NCT04784442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 120mg of ETC-1002(bempedoic acid)
Description: 120mg, tablet, once daily, for 12 weeks
Study NCT04784442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 60mg of ETC-1002(bempedoic acid)
Description: 60mg, tablet, once daily, for 12 weeks
Study NCT04784442 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo, tablet, once daily, for 12 weeks
Study NCT06515795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric exercise
Description: In each arm, participants will execute an isometric exercise, in which they will perform 4 repetitions of 2 minutes.
Study NCT04813367 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery of twisted fallopian tubes
Description: Patients diagnosed with twisted fallopian tube go through surgery.
Study NCT05368701 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Volitional Help Sheet for self-harm
Description: The volitional help sheet (VHS) is a brief psychosocial intervention that significantly reduces thoughts and acts of self-harm in adults admitted to hospital following an initial episode of self-harm. It is based on IF-THEN statements that help people link critical situations to alternative appropriate responses. An example is: If I feel the urge to self-harm when I want to get relief from a terrible state of mind, then I will do something else instead of self-harming. IF-THEN statements are intended to act as automatic coping responses, especially in cases where people may feel the urge to self-harm.~The VHS has previously been successful in reducing self-harm in people recently admitted to hospital for self-harm. Recent data have also demonstrated that a web-based version of the VHS was acceptable among a large representative sample of UK adults with self-harm experiences. However, it is yet to be known whether this intervention is effective and acceptable among adolescents.
Study NCT05368701 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Volitional Help Sheet for self-harm
Description: The volitional help sheet (VHS) is a brief psychosocial intervention that significantly reduces thoughts and acts of self-harm in adults admitted to hospital following an initial episode of self-harm. It is based on IF-THEN statements that help people link critical situations to alternative appropriate responses. An example is: If I feel the urge to self-harm when I want to get relief from a terrible state of mind, then I will do something else instead of self-harming. IF-THEN statements are intended to act as automatic coping responses, especially in cases where people may feel the urge to self-harm.~The VHS has previously been successful in reducing self-harm in people recently admitted to hospital for self-harm. Recent data have also demonstrated that a web-based version of the VHS was acceptable among a large representative sample of UK adults with self-harm experiences. However, it is yet to be known whether this intervention is effective and acceptable among adolescents.
Study NCT05466461 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Beautifil Flow Plus X.
Description: Class V cavities will be prepared, Selective etching technique will be used with phosphoric acid etching gel for 15 seconds on enamel.Single Bond TM Universal will be applied to cavity walls and margins with agitation for 20 seconds.The adhesive will be light-cured for 20 seconds. Then Beautifil Flow Plus X composite will be placed
Study NCT05466461 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Activa bioactive restorative
Description: Class V cavities will be prepared, Selective etching technique will be used with phosphoric acid etching gel for 15 seconds on enamel. Bonding agent will be applied on the entire cavity and light-cured for 20 seconds then Activa bioactive restorative composite will be applied and cured for 20 seconds.
Study NCT06191250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: one dose of durvalumab (750 mg IV)
Study NCT06772454 — intervention group
Intervention type: DRUG
Intervention: Antitumor therapy
Description: All patients received suglizumab + paclitaxel + carboplatin:~Suglizumab 1200 mg IV Q3W Paclitaxel (albumin-bound) 100 mg/m2 IV, D1, 8, 15, Q3W Carboplatin AUC=5 mg/mL/min IV Q3W A total of 4 administration cycles were given, and Suglizumab 1200 mg IV Q3W was maintained after 4 administration cycles
Study NCT06772454 — intervention group
Intervention type: DRUG
Intervention: Inhaled preparation for COPD
Description: 60 patients were randomly assigned to the following two groups in a 1:1 ratio, with about 30 patients in each group.~Group A: Receiving a long-acting beta-2 agonist (LABA) + a long-acting anticholinergic (LAMA) combination: Glonium bromide formoterol inhalation aerosol (7.2ug/5ug, trade name: Biwapin, Astrazeneca), 2 inhalations twice a day.~Group B: Received inhaled glucocorticoid (ICS) +LABA+LAMA as a three-drug combination: budesonide/glononium bromide/formoterol :160ug/7.2ug/4.8ug, Astrazeneca), 2 inhalations twice daily.
Study NCT06191250 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Non-ablative oligofractionated radiation (NORT)
Description: 12 Gy of Radiation in 3 fractions
Study NCT05067218 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: buzzy device
Description: bee shaped with wings could be frozen.
Study NCT05067218 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventinal anasthesia
Description: normal technique of injection
Study NCT06773715 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: KindVR Aqua Program
Description: For this study, patients will be introduced to a virtual reality software program called Aqua, created by the company KindVR. This software program was designed specifically for use in pediatric patients. The software has been programmed into the Pico Neo 3 headset and provides an immersive 3D experience during which the patients explore a virtual underwater world inside a submarine with a goal of providing more color to treasure and different sea animals that they will engage with along their journey. The VR experience itself lasts approximately 15 minutes
Study NCT06770114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetylpyridinium Chloride and Zinc Lactate Mouthwash
Description: 0 .075 % cetylpyridinium chloride and 0 .28 % zinc lactate
Study NCT06770114 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PhosFlur Mouthwash
Description: 0 .044 % sodium fluoride
Study NCT06772363 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serum Raman spectroscopy intelligent diagnostic system
Description: 1. Screening interested participants should sign the appropriate informed consent (ICF) prior to completion any study procedures. 2. The investigator will review symptoms, risk factors, and other non-invasive inclusion and exclusion criteria. 3. The following is the general sequence of events during the 3 months evaluation period: 4. Completion of baseline procedures Participants were assessed for 3 months and completed all safety monitoring.
Study NCT06775119 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test of neuromuscular fatigue and associated hemodynamic responses
Description: Baseline measurements of neuromuscular function and hemodynamic responses will be done. Investigators will then assess the mechanoreflex activation using the experimental technique of passive leg movement (PLM).~Following the PLM and the neuromuscular function baseline assessments, participants will perform four consecutive blocks, each consisting of a fatigue task followed by post-exercise circulatory occlusion (PECO). Neuromuscular function, assessed through maximal voluntary contraction (MVC) and quadriceps twitch techniques, will be measured before the fatigue task and after PECO in each block. Participants will perform 2-minutes isometric quadriceps sustained contraction at 20% MVC to induce exercise-induced neuromuscular fatigue. Hemodynamic responses will be measured during the PECO to isolate to the metaboreflex by inflating a cuff over the right thigh for a 2 minutes duration. After the PECO, the thigh cuff will be deflated, and neuromuscular function will be reassessed.
Study NCT06775015 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serum Raman spectroscopy intelligent diagnostic system
Description: Serum Raman spectroscopy intelligent diagnostic system Description: 1. Screening interested participants should sign the appropriate informed consent (ICF) prior to completion any study procedures. 2. The investigator will review symptoms, risk factors, and other non-invasive inclusion and exclusion criteria. 3. The following is the general sequence of events during the 3 months evaluation period: 4. Completion of baseline procedures Participants were assessed for 3 months and completed all safety monitoring.
Study NCT06773832 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Real-time Artificial Intelligence Model for Diagnosing Colorectal Polyp Pathology and Endoscopic Classification
Description: During the AI model development phase, the aim is to include as many samples as possible. Given the focus on the diagnostic accuracy of serrated lesions, we retrospectively collected approximately 400 cases serrated lesions with pathological diagnosis by the department of pathology at Peking Union Medical College Hospital to date. Additionally, we matched with 400 cases each of hyperplastic polyps, conventional adenomas, and early-stage colorectal cancer, totaling approximately 1600 cases.~The model employs mainstream AI classification algorithms to construct the model and compare the predictive performance of different models. Utilizing the dataset established in the first phase, which contains static images of polyp lesions along with their corresponding pathological diagnosis and endoscopic classifications, we developed and optimized the AI model. Then the model will be be compared with endoscopists in a prospective cohort to investigate the efficacy.
Study NCT06386016 — intervention group
Intervention type: OTHER
Intervention: artificial intelligence-based stethoscope
Description: artificial intelligence-based stethoscope
Study NCT04659811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200mg given intravenously (IV) on day 1 (to -1) of radiation and then every 3 weeks until progression or unacceptable toxicity
Study NCT04659811 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stereotactic Radiosurgery
Description: Given in (a) single session treatment with margin dose of 15-20 Gy to the target for a maximum target volume of 8 cc or (b) five consecutive business days treatment to total dose of 25-30 Gy to the target for a maximum target volume of 20 cc when the target volume exceeds 8 cc or the target is in proximity to critical structures